BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21176239)

  • 1. Ultrasound-targeted microbubble destruction mediated herpes simplex virus-thymidine kinase gene treats hepatoma in mice.
    Zhou S; Li S; Liu Z; Tang Y; Wang Z; Gong J; Liu C
    J Exp Clin Cancer Res; 2010 Dec; 29(1):170. PubMed ID: 21176239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-intensity focused ultrasound combined with herpes simplex virus thymidine kinase gene-loaded ultrasound-targeted microbubbles improved the survival of rabbits with VX₂ liver tumor.
    Zhou SJ; Li SW; Wang JJ; Liu ZJ; Yin GB; Gong JP; Liu CA
    J Gene Med; 2012; 14(9-10):570-9. PubMed ID: 22941868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of ultrasound microbubble carrying herpes simplex virus thymidine kinase on hepatocellular carcinoma in mice].
    Zhou SJ; Liu CA; Gong JP; Liu ZJ; Tang Y; Li SW; Xu Y; Ai ZG
    Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):276-9. PubMed ID: 20460047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of the ultrasound-targeted microbubble destruction-mediated herpes simplex virus-thymidine kinase/ganciclovir system on ovarian cancer in mice.
    Zhou XL; Shi YL; Li X
    Exp Ther Med; 2014 Oct; 8(4):1159-1163. PubMed ID: 25187815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-angiogenic gene therapy for hepatocellular carcinoma mediated by microbubble-enhanced ultrasound exposure: an in vivo experimental study.
    Nie F; Xu HX; Lu MD; Wang Y; Tang Q
    J Drug Target; 2008 Jun; 16(5):389-95. PubMed ID: 18569283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
    Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of PEI-Mn0.5Zn0.5Fe2O4 nanoparticles and pHsp 70-HSV-TK/GCV with magnet-induced heating for treatment of hepatoma.
    Tang Q; Lu M; Chen D; Liu P
    Int J Nanomedicine; 2015; 10():7129-43. PubMed ID: 26604760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models.
    Zheng FQ; Xu Y; Yang RJ; Wu B; Tan XH; Qin YD; Zhang QW
    Acta Pharmacol Sin; 2009 May; 30(5):617-27. PubMed ID: 19363518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular damage and anti-angiogenic effects of tumor vessel-targeted adenovirus-mediated herpes simplex virus thymidine kinase gene.
    Li BJ; Zhang C; Yi YX; Hao Y; Liu XP; Ou QJ
    World J Gastroenterol; 2007 Aug; 13(29):4006-10. PubMed ID: 17663519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
    Tang Q; Zhang D; Wan M; Jin L
    Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of gene therapy with the herpes simplex virus thymidine kinase gene and the bacterial cytosine deaminase gene for the treatment of hepatocellular carcinoma.
    Kuriyama S; Mitoro A; Yamazaki M; Tsujinoue H; Nakatani T; Akahane T; Toyokawa Y; Kojima H; Okamoto S; Fukui H
    Scand J Gastroenterol; 1999 Oct; 34(10):1033-41. PubMed ID: 10563675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus vector-mediated herpes simplex virus-thymidine kinase gene/ganciclovir system exhibits anti-tumor effects in an orthotopic hepatocellular carcinoma model.
    Zhu R; Chen D; Lin D; Lu F; Yin J; Li N
    Pharmazie; 2014 Jul; 69(7):547-52. PubMed ID: 25073402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.
    Sakai Y; Kaneko S; Nakamoto Y; Kagaya T; Mukaida N; Kobayashi K
    Cancer Gene Ther; 2001 Oct; 8(10):695-704. PubMed ID: 11687892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy of HSV-TK transferred by the EBV based expression vector on experimental hepatocellular carcinoma.
    Ding Q; Wu Z; Chen X; Musa AH; Hu J; Zhan Y
    J Tongji Med Univ; 2001; 21(2):122-5. PubMed ID: 11523215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
    Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrovirus-mediated herpes simplex virus thymidine kinase gene therapy approach for hepatocellular carcinoma.
    Gao Ding Cheng ; An W; Dai J
    Cell Res; 1999 Sep; 9(3):225-35. PubMed ID: 10520605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-targeted HSVtk and Timp3 gene delivery for synergistically enhanced antitumor effects in hepatoma.
    Yu BF; Wu J; Zhang Y; Sung HW; Xie J; Li RK
    Cancer Gene Ther; 2013 May; 20(5):290-7. PubMed ID: 23598435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental investigation of hepatic arterial embolism treatment with microsphere encapsulation of adenovirus with HSV-TK gene].
    Liu ZM; Li XX; Yan LN
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):462-5. PubMed ID: 19627006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suicide gene therapy for hepatocellular carcinoma cells by survivin promoter-driven expression of the herpes simplex virus thymidine kinase gene.
    Qu L; Wang Y; Gong L; Zhu J; Gong R; Si J
    Oncol Rep; 2013 Apr; 29(4):1435-40. PubMed ID: 23354806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.